BET Protein Inhibitor JQ1 Modulates Mitochondrial Dysfunction and Oxidative Stress Induced by Chronic Kidney Disease
Among the mechanisms involved in the progression of kidney disease, mitochondrial dysfunction has special relevance. Epigenetic drugs such as inhibitors of extra-terminal domain proteins (iBET) have shown beneficial effects in experimental kidney disease, mainly by inhibiting proliferative and infla...
Saved in:
Main Authors: | Sandra Rayego-Mateos (Author), Pamela Basantes (Author), José Luis Morgado-Pascual (Author), Beatriz Brazal Prieto (Author), Beatriz Suarez-Alvarez (Author), Alberto Ortiz (Author), Carlos Lopez-Larrea (Author), Marta Ruiz-Ortega (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress
by: Vanessa Marchant, et al.
Published: (2023) -
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
by: Jose Luis Morgado-Pascual, et al.
Published: (2019) -
Arsenic sulfide amplifies JQ1 toxicity via mitochondrial pathway in gastric and colon cancer cells
by: Tan Z, et al.
Published: (2018) -
Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis
by: Lucia Tejedor-Santamaria, et al.
Published: (2022) -
Pharmacological Modulation of BET Family in Sepsis
by: Nian Wang, et al.
Published: (2021)